Webinar call stated " Successful Ph2a "
Let's hear what the experts have to say in a few minutes.
GLTA
- Forums
- ASX - By Stock
- ACW
- Ann: ACW XanaCIDD phase 2a trial topline results
Ann: ACW XanaCIDD phase 2a trial topline results, page-41
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.21M |
Open | High | Low | Value | Volume |
2.8¢ | 2.8¢ | 2.7¢ | $191.0K | 6.985M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 582357 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 1503885 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1749904 | 0.026 |
26 | 5563699 | 0.025 |
11 | 3015971 | 0.024 |
9 | 1114000 | 0.023 |
4 | 1740663 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 1447852 | 7 |
0.029 | 1720577 | 5 |
0.030 | 3211371 | 15 |
0.031 | 3156072 | 8 |
0.032 | 1378289 | 6 |
Last trade - 10.59am 14/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online